As Prescription Painkiller Overdoses Mount, Researchers Outline Effective Approaches to Curb Epidemic

October 01, 2012

WASHINGTON—Prescription painkillers are responsible for more fatal overdoses in the United States than heroin and cocaine combined. And while most states have programs to curb abuse and addiction, a new report from Brandeis University shows that many states do not fully analyze the data they collect.

Experts from the Prescription Drug Monitoring Program Center of Excellence at Brandeis University’s Heller School for Social Policy and Management systematically assessed prescription drug monitoring programs and found a patchwork of strategies and standards. Their report also outlines best practices that all U.S. states and territories can use to improve their effectiveness.

"An epidemic of prescription drug abuse is devastating American families and draining state and federal time, money and manpower," said Rep. Hal Rogers (R-Ky.), chairman of the House Appropriations Committee. "Law enforcement and health officials are doing heroic work and, thankfully, this report provides a roadmap to help them further."

Among the study’s primary conclusions: prescription drug monitoring programs should shift from a reactive to a proactive approach.

"Being proactive is the key to success in the fight against prescription painkiller abuse," said John L. Eadie, Director, PDMP Center of Excellence at the Heller School for Social Policy and Management, Brandeis University. "While doctors may routinely collect and report data to a state program that signals where and when prescription painkillers are likely being misused, the program might not share that information with others who can best use it."

"State programs should analyze the data they collect," Peter Kreiner, Principal Investigator of Brandeis’ Center of Excellence, continued, "and reach out to prescribers, pharmacists, insurers, law enforcement agents and others who can prevent powerful narcotics from falling into the wrong hands. Where this is already taking place, it has proven to be very effective."

"Good things happen when state prescription drug monitoring programs shift to a proactive strategy," said Dr. Nathaniel Katz, assistant professor of anesthesia at Tufts University School of Medicine. "Not only can it prevent painkillers from being misused or distributed illegally in the first place, but it can also enable health professionals to identify patients who need help overcoming addiction."

By the end of 2001, the report found that 16 states had authorized the creation of prescription drug monitoring programs; within 11 years that number had grown to 49. Today, 41 states have programs in operation.

The paper identified several practices with demonstrated effectiveness. For example:

  • States that collected prescribing data for all controlled substances (e.g., anti-anxiety medication as well as painkillers) reported lower rates of doctor-shopping (visiting multiple doctors to obtain prescriptions) than other states.
  • The rates of fatal painkiller overdoses grew more slowly in three states using state-issued prescription forms with uniquely configured page numbers, a practice designed to curb fraud.
  • Proactively sending alerts about possible abuse to physicians and pharmacists was associated with decreased prescription sales and lower rates of doctor-shopping.
  • Analyzing trend data helped law enforcement agencies identify “pill mills” that were illicitly distributing prescription painkillers.
  • Boosting doctors’ participation in and utilization of prescription drug monitoring programs was associated with reduced fatal prescription painkiller overdoses.

"BJA has historically provided strong support for the promulgation and dissemination of best practices," said Denise O’Donnell, Director of the Bureau of Justice Assistance, U.S. Department of Justice, "and we are gratified by the publication of this paper, which provides much needed guidance and support for how states can most effectively utilize their prescription drug monitoring programs."

The Pew Health Group, a division of The Pew Charitable Trusts, provided funding for the research.

"Protecting patients from medical risks and ensuring their access to safe and effective therapies are significant goals for Pew," said Allan Coukell, director of medical programs for the Pew Health Group. “Prescription painkillers clearly play an important role in modern medicine, but their abuse is also responsible for mounting deaths, suffering and health care costs. These researchers’ work will advance the vital actions already being taken to attack this problem."

About Pew Health Group
The Pew Health Group conducts research to form pragmatic policies that prevent unnecessary health risks. It is part of The Pew Charitable Trusts, a nonprofit organization that applies a rigorous, analytical approach to improve public policy, inform the public and stimulate civic life. Learn more at www.PewHealth.org.

Media Contact

The Heller School welcomes media inquiries on this and all other news items. Email  Linda Paris or call 202-540-6354.

Also in the News

Judge Kavanaugh’s Supreme Court Nomination Could Put the Americans With Disabilities Act in Danger

July 26, 2018

In Rewire.News, Robyn Powell says 28-years-ago, the Americans with Disabilities Act (ADA) became law. But Judge Kavanaugh’s Supreme Court Nomination nomination could threaten it.

Inside Google’s Shadow Workforce

July 25, 2018

In Bloomberg, David Weil says we have allowed businesses to really sever their responsibility for more and more of the people who create value.

The Health 202: ACA’s medical device tax once again on the chopping block

July 25, 2018

In the Washington Post, Andrew Kolodny says it was interesting that Purdue Pharma seemed to initially acknowledge the risk of opioid prescriptions.

News Archive →